Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients. A Double-blind Randomized Controlled Trial

NCT02244879 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT02244879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02244879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients. A Double-blind Randomized Controlled Trial
Lead sponsor
University of Turin, Italy
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
February 29, 2016
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation, insulin resistance, other disorders of bone density and structure, type 2 diabetes mellitus